Economy

Zacks Investment Research Upgrades Redhill Biopharma Ltd. (RDHL) to Hold

RedHill Biopharma Ltd., launched on August 3, 2009, is a biopharmaceutical company. FBR & Co reissued an "outperform" rating and issued a $25.00 price target (down from $36.00) on shares of RedHill Biopharma Ltd - in a research note on Friday, February 24th. Finally, UBS AG initiated coverage on Redhill Biopharma in a research note on Wednesday, September 13th. The consensus rating is 3, suggesting the market has given up on the stock.

Based on the latest brokerage notes which have been released to investors, 0 brokers have issued a rating of "strong buy", 3 brokers "buy", 0 brokers "neutral", 0 brokers "sell" and 0 brokers "strong sell".

Day traders strive to make money by exploiting minute price movements in individual assets (usually stocks, though currencies, futures and options are traded as well), usually leveraging large amounts of capital to do so, therefore they trade on Stocks in Play.

The share price of the company (RDHL) was up +10.56%, with a high of 10.10 during the day and the volume of Redhill Biopharma Ltd. shares traded was 228773. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders. Current price places the company's stock -27.61% away from its 200-day simple moving average, -15.48%, away from the 50-day average and also -4.6% away from 20-day average. The firm's market capitalization is $185.53 million. RedHill Biopharma Ltd - has a 52-week low of $8.77 and a 52-week high of $16.54.

Shares of Redhill Biopharma (NASDAQ:RDHL) opened at 9.46 on Wednesday.

As of the latest earnings report the EPS was $-2.46 and is expected to be $-2.36 for the current year with 17,163,000 shares now outstanding. The business had revenue of $0.48 million during the quarter, compared to analysts' expectations of $0.34 million. Equities analysts forecast that Redhill Biopharma will post ($2.36) EPS for the current fiscal year. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of United States & worldwide copyright & trademark laws. If you are viewing this story on another domain, it was stolen and republished in violation of United States and worldwide copyright law.

Current levels places RedHill Biopharma Ltd. (NASDAQ:RDHL)'s stock about -1.28% from the 50-day high and 32.20% away from the 50-day low. Investors might also notice that three month ago the Buy recommendations (3) outnumbered Sell recommendations (0). Family Management Corp lifted its stake in shares of Redhill Biopharma by 51.5% in the 2nd quarter. Family Management Corp claims 25,750 shares worth $222,000. Oppenheimer & Co. Inc. raised its position in shares of Redhill Biopharma by 10.8% during the second quarter. Oppenheimer & Co. Inc. now owns 25,569 shares of the biotechnology company's stock worth $220,000 after acquiring an additional 2,500 shares during the period. Bank of New York Mellon Corp acquired a new stake in Redhill Biopharma during the 1st quarter worth approximately $101,000. Bank of New York Mellon Corp now owns 12,005 shares of the biotechnology company's stock valued at $103,000 after acquiring an additional 1,440 shares during the last quarter. Jane Street Group LLC purchased a new stake in shares of Redhill Biopharma during the first quarter worth $276,000.

Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company.



Like this

Latest


30 September 2017
Insiders Selling, Short Interest Growing Ormat Technologies, Inc. (NYSE:ORA)
Oppenheimer has "Buy" rating and $65 target. (NYSE:ORA) has "Mkt Outperform" rating given on Monday, December 19 by Avondale. The company's shares were given away at $59.5 per share worth to an income of some $685,619 on account of Argas Shlomi.

30 September 2017
California Lawmaker Wants To Stop Gas And Diesel Car Sales After 2040
No one has yet explained how the state plans to deal with phasing out existing cars, including valuable classic and exotic cars. Mary Nichols, the chairwoman of the California Air Resources Board, told Bloomberg in a recent interview that Gov.

30 September 2017
Hazard must be more ruthless to reach Messi, Ronaldo levels - Conte
The two clubs clash at Stamford Bridge this weekend, with both in confident mood after fine starts to the season. I like players who are used to thinking about the team and are used to thinking about "us", not "me".

30 September 2017
Madonna uses $600 mask on her butt to keep the skin soft
She is clearly proud of the skincare line , which she co-developed with Japanese company MTG and her own dermatologist, Dr. Don't other people look at your butt? "It's a little bit weird".

30 September 2017
Thousands of nightlight soothers recalled over electrical shock hazard
The shock risk may be present in the owl and elephant lights, with an outlet adapter with certification number E479473. At least one incident of electric shock has been reported to Skip Hop as a result of the power adapter breaking.

30 September 2017
Moon urges bipartisan efforts to overcome N. Korean nuclear threat, ensure growth
If North Korea follows through with a hydrogen bomb nuclear test over the Pacific, radioactive fallout could be catastrophic. Overseas Chinese joint ventures with North Korean entities or individuals will also be closed, the ministry said.

30 September 2017
Abbott Laboratories (ABT) Hits a 52-Week High
Following the completion of the transaction, the insider now directly owns 28,806 shares in the company, valued at $1,416,102.96. Moreover, Forbes J M And Ltd Liability Partnership has 0.11% invested in Abbott Laboratories (NYSE: ABT ) for 8,923 shares.

30 September 2017
Quarterly Financial Review of American Eagle Outfitters, Inc. (NYSE:AEO)
The brokerage now has $15.00 price objective on the apparel retailer's stock, down from their prior price objective of $18.00. Dalton Greiner Hartman Maher & Co acquired 549,183 shares as American Eagle Outfitters New ( AEO)'s stock declined 29.04%.

30 September 2017
Analysts Ratings for Dick's Sporting Goods Inc. (DKS)
Following the completion of the purchase, the director now directly owns 323,224 shares in the company, valued at $8,484,630. This is just the latest partnership that Dick's Sporting Goods has forged with a national youth sports organization.

30 September 2017
Were Analysts Bullish Franco Nevada Corp (TSE:FNV) This Week?
The firm owned 20,649 shares of the basic materials company's stock after acquiring an additional 9,630 shares during the quarter. AQR Capital Management LLC grew its position in shares of Franco-Nevada Corporation by 1.5% in the first quarter.



Recommended